Insightful Analysis of BMY's Strengths, Weaknesses, Opportunities, and Threats
Bristol Myers Squibb stock gapped higher Friday after the Big Pharma stalwart beat June-quarter forecasts and raised its outlook.
Stocks rose sharply Friday after the personal consumption expenditures price index, the report the Federal Reserve considers the most accurate measure of price inflation, matched expectations. The data have analysts and economists expecting an interest-rate cut from the Fed in September.